DOR BioPharma Opens New Corporate Office In United Kingdom DOR BioPharma, Inc. (OTCBB: DORB), a late-stage biopharmaceutical company developing products to treat life-threatening side effects of cancer treatments and serious gastrointestinal diseases, and vaccines against certain bioterrorism agents, announced that it has opened a new corporate office in the United Kingdom (UK).
Source: www.medicalnewstoday.comLabels: No Prescription, Online Pharmacy
# posted by Network @ 4:00 PM
